Status:
UNKNOWN
Clinical Study of TEAS Intervention in Relieving Anxiety Before Thoracoscopic Surgery
Lead Sponsor:
Shanghai Yueyang Integrated Medicine Hospital
Conditions:
Acupuncture Therapy
Preoperative Period
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This single-center randomized sham-controlled trial will be conducted in cardiothoracic surgery department of the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine in China. A to...
Detailed Description
This single center, randomized, sham-controlled, participant-blinded and assessor-blinded trial will be conducted at the inpatient ward of cardiothoracic surgery department of Yueyang Hospital of Inte...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Those diagnosed as pulmonary nodules requiring VATS.
- Age between 18 and 75 years old.
- 4 ≤ GAD-7 score ≤ 9 and those who have no previous mental illness and have not used anti-anxiety or psychotropic drugs within 2 weeks.
- Those who have clear consciousness, normal understanding, no expression barriers, can cooperate with treatment and have signed an informed consent.
- Patients who have not received TEAS treatment in the past.
- Patients who have not participated or participating in other clinical trials one month before enrollment.
- Exclusion criteria
- Patients with skin infections in local meridian points.
- Patients with upper or lower limb nerve injury.
- Patients who had been implanted pacemaker.
- Rejection, suspension and dropout criteria
- Those with serious adverse reactions.
- Those who presented worsen symptoms or life-threatening illnesses that cannot be continued during treatment.
- The principal investigator asserts that there are unacceptable risks for serious adverse events during the study.
- Patients who cannot cooperate to complete the research plan, including language difficulties, infectious diseases and other medical history.
- Patients quit by themselves.
Exclusion
Key Trial Info
Start Date :
January 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04895852
Start Date
January 11 2023
End Date
December 31 2023
Last Update
January 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Yueyang Integrated Medicine Hospital
Shanghai, China